..., but whether this combination therapy was able to improve the efficacy remains unknown. Therefore, we designed this prospective, single-arm, open-label trial to investigate the efficacy of imatinib-based combination therapy in the treatment of SR-cGVHD for the first time. Methods: Sixty SR-cGVHD patients were...

... and the term ‘combination’ has been associated with very different regimes of chelation. However, combination therapy should indicate the assumption of both DFO and DFP treatment on the same day either simultaneously (i.e. DFP taken before breakfast, lunch, and dinner with subcutaneous DFO infusion during...